Encelo Laboratories company
Universal access to primary cells
Founded Date:
2017-12-01
Last Funding Type:
Seed
Headquarters:
London, England, United Kingdom
Investors Number:
2
Technology:
P4 Medicine
Employee Number:
1-10
Industry:
Biotechnology, Science and Engineering
Estimated Revenue:
Less than $1M
Funding Status:
Seed
Investor Type:
For Profit